← Back to Search

Suicidal Adolescent for Suicide

N/A
Recruiting
Led By David Sheridan, MD
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up four times daily up to one week
Awards & highlights

Summary

The central hypothesis is that biometric data can continuously monitor and allow for early identification/intervention of escalating suicidal symptoms. The rationale is that improved outpatient monitoring through wearable technology can create a more objective platform to provide the ability to identify a worsening condition and utilize patient-specific just-in-time therapeutics developed with mental health providers for suicidal adolescents.

Eligible Conditions
  • Mental Health Issue
  • Suicide

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~four times daily up to one week
This trial's timeline: 3 weeks for screening, Varies for treatment, and four times daily up to one week for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Heart rate variability and Suicidality

Trial Design

1Treatment groups
Experimental Treatment
Group I: Suicidal AdolescentExperimental Treatment1 Intervention
he study will enroll subjects aged 13-17 years admitted with a chief complaint of acute suicidality or attempt. Patients will undergo physiologic and biometric monitoring in the hospital with a wrist-wearable device and chest wall ECG leads. They will undergo serial assessment four times daily to gather data regarding their activities, affect, and suicidality.

Find a Location

Who is running the clinical trial?

Oregon Health and Science UniversityLead Sponsor
985 Previous Clinical Trials
7,385,580 Total Patients Enrolled
2 Trials studying Suicide
4,250 Patients Enrolled for Suicide
Analog Device, Inc.OTHER
13 Previous Clinical Trials
1,950 Total Patients Enrolled
David Sheridan, MDPrincipal InvestigatorOregon Health and Science University
3 Previous Clinical Trials
424 Total Patients Enrolled
1 Trials studying Suicide
250 Patients Enrolled for Suicide
~54 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top